drugset / Trial / NCT00155675
Pseudodrynaria Coronana (Wall) Ching
Phase 1
Completed
120 enrolled
National Taiwan University Hospital
Sheng Chang Pharmaceutical · collab
RandomizedSingle-groupDouble-blindTreatment
Summary
The Study to evaluate the clinical effect of "Gusuibu" lasts for 3 years. It aims to evaluate its effect on bone density of postmenopausal osteoporosis. Besides, its effects on the liver, kidney and the hematological influence will be evaluated, too.
Timeline
- Start
- 2000-01
- Primary completion
- —
- Completion
- 2001-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gusuibu | Traditional medicine (herbal / TCM) | — | — |